tbuckley/cabot-search huggingface dataset:
Targeted Lymphocyte Depletion: A Personalized Approach to Achieve Rapid Complete Donor Chimerism and Enhance Graft-Versus-Tumor Effects Following Reduced Intensity Allogeneic Stem Cell Transplantation for High-Risk Hematologic Malignancies.
Authors: Rachel B. Salit, Seth Steinberg, Daniel H. Fowler, Jeanne Odom, Kelly Bryant, Michael R. Bishop
Journal: Blood (2009)
Acute Gvhd Induced by In Utero Hematopoietic Cell Transplantation Is Reversed by a Regulatory Response Resulting in a Potent Graft Vs. Hematopoietic Effect without Clinical Gvhd
Authors: Miho Watanabe, Jesse Vrecenak, Jacqueline Tsai, Jason Sulkowski, Edem Timpo, Haying Li, Alan W Flake
Journal: Blood (2011)
P08.05 Combined presence of three MGMT gene-polymorphisms in a glioblastoma patient, who developed severe myelosuppression following temozolomide chemotherapy
Authors: M. A. Altinoz, E. Ozek, C. G. Ekmekci, G. Yenmis, I. Elmaci
Journal: Neuro-Oncology (2016)

AbstractIntroduction:Temozolomide chemotherapy can cause thrombocytopenia or neutropenia in 3 and 4 percent of patients, respectively; however pancytopenia cases were very rarely reported. MGMT (O6-methylguanine-DNA-methyltransferase) enzyme repairs temozolomide-induced guanine base mutations in the DNA and it is important both for the tumor response and myelotoxic side effects in glioblastoma patients. DNA repair mechanisms exert diverging effects on DNA injuries caused by different mutagens; and hence, the same variants of the same DNA repair genes may differentially influence cytotoxic or tumorigenic DNA damage. Until recently, only one case-series study exists which showed that rs2308321 and rs2308327 variants of the MGMT-gene is related with general myelotoxicity of temozolomide. Another study have reported rs12917 variant of the MGMT-gene in two patients with temozolomide-induced severe myelosuppression.Materials and Methods:We performed full-sequencing of the MGMT gene (via Applied Biosystems Biosequencing®) in a female glioblastoma patient, who developed pancytopenia and sepsis following temozolomide treatment.Results:We have encountered that this patient carried all the rs2308321, rs2308327 and rs12917 variants of the MGMT-gene associated with temozolomide myelotoxicity. Interestingly, rs12917 variant was previously reported to associate with lesser risks of gallbladder cancer and glial tumors and with higher risk of non-Hodgkin lymphomas following exposure to organic chlorinated solvents or hair-dyes.Conclusions:The sum effect of multiple rare variants and/or coexposure to multiple environmental mutagens may have triggered glioblastoma formation and myelotoxicity in this patient. In future, routine full-sequencing of MGMT gene may help to predict patients with high risk of temozolomide-toxicity.
A Phase I Study of the Safety and Pharmacokinetics of Escalating Doses of MFGR1877S, a Fibroblast Growth Factor Receptor 3 (FGFR3) Antibody, in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma
Authors: Suzanne Trudel, P. Leif Bergsagel, Seema Singhal, Ruben Niesvizky, Raymond L. Comenzo, William I. Bensinger, Daniel Lebovic, YounJeong Choi, Dan Lu, Dorothy French, Elicia Penuel, William Ho, Keith Stewart
Journal: Blood (2012)
Ibrutinib Targets Nurse-like Cells Supporting an Immunosuppressive Phenotype in Chronic Lymphocytic Leukemia
Authors: Stefania Fiorcari, Rossana Maffei, Valentina Audrito, Silvia Martinelli, Elisa Ten Hacken, Giulia Grisendi, Patrizia Zucchini, Chiara Quadrelli, Mario Luppi, Jan A. Burger, Silvia Deaglio, Roberto Marasca
Journal: Blood (2015)
FRI0381 Pattern of Clinical Presentation and Outcome of Polymyalgia Rheumatica
Authors: A. Sobrero, D. Camellino, C. Cosso, C. Pizzorni, M. Cutolo, M.A. Cimmino
Journal: Annals of the Rheumatic Diseases (2016)

<h3>Background</h3> Polymyalgia rheumatica (PMR) is an inflammatory disorder of the elderly characterized by girdle pain and stiffness, constitutional symptoms and elevation of inflammatory indexes. Glucocorticoid (GC) treatment is effective but often prolonged, with associated side effects. Data on risk factors of poor prognosis are scanty: in particular it is not known if the pattern of clinical presentation can influence PMR outcome. <h3>Objectives</h3> To test the hypothesis that clinical presentation of PMR can predict its outcome. <h3>Methods</h3> 394 patients (251 women, median age 73 yrs, range 47–92 yrs) with PMR diagnosed according to Bird9s criteria, visited between 1990 and 2014 by the same clinician were studied. Median follow up was 13.8 months (range 1–250 months). Clinical features recorded at disease presentation included involvement of: i) the shoulder girdle; ii) the pelvic girdle; iii) the column; vi) two or more of the previous locations; v) with giant cell arteritis (GCA); or vi) with acute onset, defined as completion of full symptoms and signs in ≤72h. PMR outcome was evaluated by considering: i) duration of follow-up; ii) appearance of peripheral arthritis; iii) appearance of GCA; iv) number of exacerbations/ relapses; v) cumulative dosage of GC; vi) use of methotrexate (MTX); and vii) death. <h3>Results</h3> At multivariate analysis, acute onset predicted a longer follow-up duration (p=0.007) and death (p=0.037); involvement of the spine predicted longer follow up duration (p=0.001) and use of MTX (p=0.018); presentation at the pelvic girdle predicted a high number of exacerbations/relapses (p=0.034) and association therapy with MTX (p=0.009); onset in multiple locations predicted a high number of exacerbations/relapses (p=0.03); presentation with GCA predicted a higher cumulative dosage of GC (p=0.0001) and use of MTX (p=0.027). <h3>Conclusions</h3> Apart from the obvious association between concomitant GCA and negative prognosis of PMR, other clinical characteristics at disease onset influence outcome. In particular, the initial presentation with multiple locations, including spine and pelvic girdle, resulted in longer follow-up, more relapses, and need of MTX treatment, whereas the classic one with only shoulder girdle involvement was associated with a milder disease. An acute onset was also a negative prognostic factor. Clinicians should consider the pattern of disease presentation when evaluating the burden of PMR. <h3>Disclosure of Interest</h3> None declared
SP0133 Do We Need New Proms or Can We Reuse Them?
Authors: S. Hewlett
Journal: Annals of the Rheumatic Diseases (2016)

The re-use of validated PROMs from one condition into a different condition is common. However, this is often done without understanding the conceptual model of the particular health issue that the PROM attempts to capture in the first population, nor its formulation in the new target population (face and content validity). Furthermore, there is often no attempt to explore psychometric evidence for validity in the new patient population (construct, criterion, sensitivity and reliability). Second, once a PROM has been developed in the initial language, there are instances when researchers simply translate the words, without considering cultural issues in the new population. The original PROM developers may not be involved in ensuring conceptual equivalence of the health issue between the old and new populations, let alone cultural transferability. These new translations need evaluating fot only for cultural and conceptual equivalence, but also psychometric validity. Such work has implications for cost and time, but there are good examples of robust and well-thought through translation protocols by either researchers or PROM translation companies. This presentation will explore these re-use issues and provide examples of good practice (or otherwise). <h3>Disclosure of Interest</h3> S. Hewlett Grant/research support from: Unrestricted educational grant from GSK towards PhD student to develop a questionnaire, Consultant for: Institution received funding to support translation of questionnaire, from UCB and Bristol Myers Squibb
A Phase II Study with ICL670 (Exjade®), a Once-Daily Oral Iron Chelator, in Patients with Various Transfusion-Dependent Anemias and Iron Overload.
Authors: John Porter, Elliot Vichinsky, Christian Rose, Antonio Piga, Nancy Olivieri, Norbert Gattermann, Johan Maertens, Bertrand Rabault, Insa Gathmann, Daniele Alberti
Journal: Blood (2004)
The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community
Authors: Miten Jain, Hugh E. Olsen, Benedict Paten, Mark Akeson
Journal: Genome biology (2016)

Nanopore DNA strand sequencing has emerged as a competitive, portable technology. Reads exceeding 150 kilobases have been achieved, as have in-field detection and analysis of clinical pathogens. We summarize key technical features of the Oxford Nanopore MinION, the dominant platform currently available. We then discuss pioneering applications executed by the genomics community.
Mutations Identified in Thrombocytopenia THC2 Are Likely to Dysregulate ANKRD26 Expression
Authors: Chiara Gnan, Patrizia Noris, Felisa C. Molinas, Shinji Kunishima, Paula Graciela Heller, Akihiro Iguchi, Alessandro Pecci, Erica Valencic, Seri Marco, Silverio Perrotta, Carlo Luigi Balduini, Anna Savoia
Journal: Blood (2011)
Correlations Between Pancreatic Iron Burden and Heart Iron Overload and Function by MRI in a Large Cohort of Thalassemia Major Patients.
Authors: Antonella Meloni, Gennaro Restaino, Massimiliano Missere, Vincenzo Positano, Nicola Romano, Giuseppe Serra, Rino Biguzzi, Lucia De Franceschi, Brunella Favilli, Giuseppina Sallustio, Massimo Lombardi, Alessia Pepe
Journal: Blood (2012)
Differentiated selves can surely be good for the group, but let's get clear about why
Authors: Sanaz Talaifar, William B Swann
Journal: Behavioral and Brain Sciences (2016)

Abstract We applaud the goal of reconciling the self and group literatures and agree that a differentiated self may sometimes improve group outcomes. Nevertheless, greater precision regarding the underlying mechanisms is needed. Specifically, differentiated selves improve outcomes by overriding selfishness when they allow for personal regulation (being personally recognized and valued) rather than social regulation (specialization of labor).
Bone Marrow-Derived, BCR/ABL+ and Flk1+CD31−CD34− Stem Cells from CML Patients That Are Insensitive to STI571 In Vitro.
Authors: Yongping Song, Baijun Fang, Yanli Zhang, Xudong Wei, Lulu Lu, Xinhu Zhu, Ping Wang, Yufu Li, Quanli Gao, Guiye Wang, Lugui Qiu, Chunhua Zhao
Journal: Blood (2005)
Molecular Aberrations in 107 Children with Myelodysplastic Syndrome (MDS).
Authors: Andrica de Vries, Christian M. Zwaan, Joop H. Jansen, Michael Dworzak, Henrik Hasle, Franco Locatelli, Barbara De Moerloose, Suzan J.C.M. Arentsen-Peters, Valerie de Haas, Sophia Polychronopoulou, Jan Stary, Markus Schmugge, Marco Zecca, Owen Smith, A. Catala, Brigitte Schlegelberger, H. Berna Beverloo, Rob Pieters, Charlotte M Niemeyer, Marry M. van den Heuvel
Journal: Blood (2012)
In CVD with moderate-to-severe obstructive sleep apnea, adding CPAP to usual care did not reduce major CV events
Authors: Sandeep Arepally, Amy R. Blanchard
Journal: Annals of Internal Medicine (2016)

Source Citation McEvoy RD, Antic NA, Heeley E, et al; SAVE Investigators and Coordinators. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375:919-31. 27571048
Genomic Profiling of Different Subtypes of B-Cell Non-Hodgkin’s Lymphoma Using High-Density Single Nucleotide Polymorphism (SNP) Microarrays.
Authors: Motohiro Kato, Kumi Nakazaki, Kengo Takeuchi, Go Yamamoto, Yasuhito Nannya, Masashi Sanada, Satsuki Muto, Shigeru Chiba, Shigeo Mori, Yukio Kobayashi, Mineo Kurokawa, Seishi Ogawa
Journal: Blood (2007)
SAT0202 Nailfold Microangiopathy Extent and Choroidal Vascular Thickness Evaluated by Nailfold Videocapillaroscopy and Optical Coherence Tomography in Systemic Sclerosis Patients
Authors: E. Bernero, A. Sulli, C. Pizzorni, S. Paolino, E. Alessandri, M. Nicolò, C.E. Traverso, C.A. Cutolo
Journal: Annals of the Rheumatic Diseases (2016)

<h3>Background</h3> Systemic sclerosis (SSc) is a connective tissue disease characterized by progressive microvascular involvement (1). Nailfold videocapillaroscopy (NVC) represents the best and safest method to detect and to follow the progression of morphological microvascular SSc abnormalities (2). Microvascular alterations in SSc are observed in several organs, including the choroidal plexus of the eye (3). Modern optical coherence tomography (OCT) imaging and analysis have allowed the choroid to become observable and measurable (4). An overall thinning of choroidal layer has been observed in SSc patients consistent with an impairment of choroidal perfusion; the process becomes progressively more severe and extensive in overt SSc (5). <h3>Objectives</h3> To compare severity of nailfold microvascular damage with the choroidal thickness, as assessed by NVC and OCT. To evaluate OCT plausibility in SSc staging. <h3>Methods</h3> Twelve SSc patients according to recent ACR/EULAR classification criteria (6) (disease duration 4.8 ± 2.8 years, age 58±13 years) underwent NVC (4 "early", 3 "active", 5 "late" scleroderma NVC pattern) and ophthalmologic examination by OCT. NVC patterns were scored by quantitative rating scale and the "microangiopathy evolution score (MES)" was calculated (7). OCT images were recorded by 3D-2000 OCT using protocol "line" that averages 50 B-scans and generates a horizontal 6 mm line. Choroidal thickness area measurements were performed manually using image J software. Statistical analysis was performed by non parametric tests. <h3>Results</h3> Despite the limited number of enrolled SSc patients, a statistically significant negative correlation was observed between the progressive severity of the microvascular damage score (MES) and the choroidal thickness values (OCT) (r=-0.39, p=0.05). <h3>Conclusions</h3> Nailfold microangiopathy evolution, as evaluated by NVC in SSc patients, seems to correlate with the choroid thickness, as assessed by OCT. Microangiopathy progression seems to involve the choroidal plexus by showing a thinner layer thickness in SSc patients. Therefore, OCT may be useful in the evaluation of possible retinal microvascularization damage in SSc patients. <h3>References</h3> Herrick AL, et al. Rheum Dis Clin North Am. 2008;34:89–114. Cutolo M, et al. Arthritis Rheum. 2007;56:2102–2103. Farkas TG, et al. Am J Ophthalmol 1972;74:875–886. Yamashita T, et al. Invest Ophthalmol Vis Sci 2012;53:1102–1107. Ingegnoli F, et al. Microvasc Res 2015;97:31–36. Van den Hoogen F, et al. Ann Rheum Dis. 2013;72:1747–55. Sulli A, et al. Ann Rheum Dis 2008;67:885–887. <h3>Disclosure of Interest</h3> None declared
Recent Interim Analysis of the HD11 Trial of the GHSG: Intensification of Chemotherapy and Reduction of Radiation Dose in Early Unfavorable Stage Hodgkin’s Lymphoma.
Authors: Volker Diehl, Corinne Brillant, Andreas Engert, Ralf-Peter Mueller, Hans-Theodor Eich, Konrad Mueller-Hermelink, Richard Herrmann, Jana Markova, Anthony Ho, Wolfgang Hiddemann, Bernd Doerken, Richard Greil, Andreas Josting, Beate Pfistner
Journal: Blood (2005)
Inhibition of Hypusination of Eukaryotic Initiation Factor 5a (eIF-5A) as a Novel a Synergistic Treatment Strategy in Imatinib-Treated BCR-ABL Positive Leukemias Identified by a Global Proteomics Approach.
Authors: Stefan Balabanov, Patrick Ziegler, Ulricke Hartmann, Winfried Kammer, Mhairi Copland, Martin Priemer, Thomas Wilhelm, Carsten Bokemeyer, Lothar Kanz, Tessa Holyoake, Alfred Nordheim, Tim Bruemmendorf
Journal: Blood (2005)
The Incidence and Risk Factors of the Euthyroid Sick Syndrome Soon after Allogeneic Hematopoietic Stem Cell Transplantation in Children.
Authors: Bin Cho, Dae-Hyoung Lee, Dae-Chul Jeong, Young-Joo Kwon, Pil-Sang Jang, Nak-Gyun Chung, Hack-Ki Kim, Hui Sung Hwang, Young-Shil Park, Sun Young Kim, Ji Kyoung Park
Journal: Blood (2006)
FRI0536 A New System for Investigating Capillary Morphology and Blood Flow in Systemic Sclerosis
Authors: M. Berks, G. Dinsdale, A.K. Murray, T. Moore, S. Rhodes, C. Taylor, A. Herrick
Journal: Annals of the Rheumatic Diseases (2016)

<h3>Background</h3> Nailfold videocapillaroscopy (NVC) captures high-magnification images of capillaries, allowing non-invasive assessment of systemic sclerosis [SSc] related microvascular disease. We have developed a state-of-the-art NVC system to enable faster and easier acquisition of high quality static images and produce video sequences in which red blood cell velocity can be measured. The system uses novel software to make fully automated quantitative estimates of capillary morphology and blood flow velocity, eliminating the need for (subjective) clinician input to image interpretation. <h3>Objectives</h3> To apply the new system in a case-control study to: 1) assess system usability 2) test how well automated measures of capillary morphology differentiate between healthy controls (HC), subjects with primary Raynaud9s phenomenon (PRP) and patients with SSc 3) investigate capillary blood flow velocity as a new quantitative measure for NVC. <h3>Methods</h3> 112 participants were recruited into the study (50 HC, 12 PRP, 50 SSc). Panoramic video sequences were taken for all 10 digits, each comprising 10,000 – 20,000 frames (size: 640x480 px, spatial resolution: 1μm/px, frame rate: 120 frames/s). The frames were processed and registered to produce a static panorama of the whole nailfold (∼2–5mm wide). The analysis software automatically detected and measured capillary structural properties in this image<sup>1</sup>, before using in-focus frames at each capillary to create video sequences for blood flow velocity estimation (Fig 1). Capillary-level measurements were averaged across all 10 nailfolds to produce subject-level parameters: capillary density, mean capillary width, maximum capillary width, shape score, derangement and mean flow velocity. For each parameter one-way ANOVA and Tukey9s range test were used to check for group differences, and the area under ROC curve (A<sub>z</sub>) used to measure separation between HC/PRP and SSc. <h3>Results</h3> ANOVA tests showed significant group-wise differences for all parameters. Table 1 shows group means and A<sub>z</sub> for each parameter. <h3>Conclusions</h3> The new system successfully generated high-quality video sequences, and allowed fast panoramic imaging of the whole nailfold. Automatically extracted capillary morphology parameters matched both clinical expectations and previous study results<sup>1,2</sup> and show considerable promise as outcome measures for SSc. Preliminary flow results suggest reduced blood velocity is associated with abnormal morphology and thus lower in SSc patients, further work is needed to corroborate this. <h3>References</h3> Berks et al, MICCAI, 8673, 658–665, 2014 Murray et al, Arthritis Care Res, 61(8), 2009 <h3>Acknowledgement</h3> Funded by the Wellcome Trust <h3>Disclosure of Interest</h3> None declared
AB0558 Juvenile-Onset Behçet's Disease: Clinical and Genetic Features Compared with Adult Onset-Disease
Authors: T. Ben Salem, I. Naceur, M. Tougorti, I. Ben Ghorbel, M. Lamloum, M.H. Houman
Journal: Annals of the Rheumatic Diseases (2016)

<h3>Background</h3> Behçet9s disease (BD) is are in children. <h3>Objectives</h3> The aim of this study was to describe clinical spectrum of BD in childhood in comparison to adult onset-disease. <h3>Methods</h3> We conducted a retrospective study over 10 years including 430 patients with the diagnosis of BD according to the criteria of the International Study Group. The patients were placed into two groups based on the age of the disease onset: group1: juvenile-onset (≤16 years) and group 2: adult-onset disease (age &gt;16 years). Clinical, genetic and therapeutic characteristics of juvenile patients were analyzed and compared with adult patients <h3>Results</h3> There were 38 cases with juvenile onset disease (24 males, 14 females; gender ratio M/F: 1.7). A family history of BD was found in 3 patients. The mean age of the disease onset in this group was 12.8 years ±2.9 and the average age at BD diagnosis was 21.55 years ±7.47. Genital ulcers were observed in 71% of cases. Skin lesions were found in 76.3% of patients and positive pathergy test in 70.4%. Nineteen patients (50% of cases) had ocular involvement (uveitis: 18 cases, retinal vasculitis: 10 patients) which was complicated of blindness in 2 cases. Neurological involvement was observed in 8 patients (21% of cases). Eight patients presented vascular lesion (superficial venous thrombosis: 5 cases, deep venous thrombosis: 3 cases), no cases of arterial involvement was noted. HLA B51 was found in 62.5% of cases. Comparative study of the 2 groups showed that children with BD had significantly less deep venous thrombosis and more superficial venous thrombosis. The ocular involvement was relatively less severe in children (blindness: 15.4% vs 32.5%). Treatment was based in colchicine, corticosteroids (73.7%) and immunosuppressant agents. Cyclophosphamides were more used in adults (45.6% vs 26.3%; p=0.02) and azathioprine in children (46% vs 33%; p=0.08). <h3>Conclusions</h3> Behçet9s disease in children is characterized in our series by the frequency of superficial venous thrombosis and seems to run a less severe course (less DVT and blindness, no arterial involvement and less use of cyclophosphamide). An appropriate and early treatment would prevent the occurrence of serious visceral complications in these patients. <h3>Disclosure of Interest</h3> None declared
Different Prognostic Significance of a Panel Cytogenetic Aberrations Between Chronic Lymphocytic Leukemia and Other B-Cell Chronic Lymphoproliferative Disorders
Authors: Wenjie Xiong, Heng Li, Shuhua Yi, Zengjun Li, Shizhen Zhong, Wei Liu, Rui Lv, Dehui Zou, Lugui Qiu
Journal: Blood (2015)
Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML
Authors: Joon Ho Moon, Sang Kyun Sohn, Soo Jung Lee, Yoo Jin Lee, Young Rok Do, Hyeoung Joon Kim, Yeo Kyeoung Kim, Young Don Joo, Chul Won Jung, Dong Hwan Kim, Myung Soo Hyun, Min Kyoung Kim, Jooseop Chung, Seonyang Park, Inho Kim, Joon Seong Park, Hawk Kim, Jinny Park, Yoo-Hong Min, June-Won Cheong, Hun-Mo Ryoo, Ki-Seong Eom, Eun Kyung Park, Moo Rim Park, Suk-Joong Oh, Byung Soo Kim, Chul Soo Kim, Dae Young Zang, Soo-Mee Bang, Hong Ghi Lee, Deog Yeon Jo, Jong Ho Won
Journal: Blood (2010)
Long-standing Onychodystrophy in a Young Woman
Authors: Shari R. Lipner, Richard K. Scher
Journal: JAMA (2016)

A 34-year-old woman has thickened toenails for more than 20 years, with subungual hyperkeratosis of all 10 toenails and scale on the plantar surface skin and in the web spaces on examination. What would you do next?
Platelet-Derived Beta Thromboglobulin: A Potential Novel Activator of Coagulation Factor X
Authors: Karl Egan, Hui Ma, Barry Kevane, Áine Lennon, Elaine Neary, Kieran Wynne, Seamus Allen, Susan O'Shea, Richard O Kennedy, Fionnuala Ní Áinle
Journal: Blood (2015)
Abdominal Obesity, IL-6 Levels and the Risk of Venous Thromboembolism Among Women: a Case-Control Study
Authors: Christiane Pereira Gouveia, Dayse Maria Lourenço, Marinez Farana Matos, Cristina Mary Orikaza, Maria Aparecida Eiko Noguti, Vânia Maris Morelli
Journal: Blood (2010)
MLN4924, a Novel Small Molecule Inhibitor of Nedd8-Activating Enzyme, Demonstrates Potent Anti-Tumor Activity in Diffuse Large B-Cell Lymphoma
Authors: Michael Milhollen, Usha Narayanan, Allison J Berger, Michael Thomas, Tary Traore, Jie Yu, Julie Zhang, Erik Koenig, James J. Garnsey, Steven P. Langston, Teresa A Soucy, Peter G Smith
Journal: Blood (2008)
Pharmacogenetic Study of Methotrexate and 6-Mercaptopurine Related Genes in Korean Pediatric Patients with Acute Lymphoblastic Leukemia.
Authors: Hyoung Jin Kang, Young-Jin Seo, Chang Jin Lee, Hyery Kim, Mi Kyung Jang, Sang Hyeok Koh, Yongtaek Oh, Byoung-Don Han, Chul Woo Kim, Eun Kyung Kim, Hee Young Shin, Hyo Seop Ahn
Journal: Blood (2007)